Profectus Biosciences

About:

Profectus Biosciences is a R&D company developing vaccine and small molecules to treat and prevent viral diseases and cancers.

Website: http://www.profectusbiosciences.com

Top Investors: Cross Atlantic Capital Partners

Description:

Profectus Biosciences is a research and development company dedicated to harnessing the immune system to treat and prevent viral diseases and cancers through the delivery of our proprietary prime/boost vaccines and small molecules.

Total Funding Amount:

$34.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2002-01-01

Contact Email:

info(AT)profectusbiosciences.com

Founders:

Robert Charles Gallo, Timothy Fouts

Number of Employees:

11-50

Last Funding Date:

2015-12-09

IPO Status:

Private

Industries:

© 2025 bioDAO.ai